StockWatch
·
Pharmaceuticals
Subsidiary19 May 2026, 07:31 pm

Gujarat Themis Biosyn Incorporates Wholly Owned Subsidiary in Japan

AI Summary

Gujarat Themis Biosyn Ltd has incorporated a wholly owned subsidiary, Themis Biosyn Japan Limited, in Japan on May 19, 2026. The share capital of the new entity is Ten Lakhs Yen. This incorporation does not fall under related party transactions and is not outside the main line of business of the listed entity.

Key Highlights

  • Gujarat Themis Biosyn establishes Themis Biosyn Japan Limited as a wholly owned subsidiary.
  • The new subsidiary is incorporated in Japan on May 19, 2026.
  • Themis Biosyn Japan Limited has a share capital of Ten Lakhs Yen.
  • The incorporation does not constitute a related party transaction.
  • Gujarat Themis Biosyn Limited holds 100% shareholding of the subsidiary.
GUJTHEM
Pharmaceuticals
GUJARAT THEMIS BIOSYN LTD.

Price Impact